• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Front Public Health . Mathematical modeling of SARS-CoV-2 variant substitutions in European countries: transmission dynamics and epidemiological in

tetano

Editor, Senior Moderator
Front Public Health


. 2024 May 15:12:1339267.
doi: 10.3389/fpubh.2024.1339267. eCollection 2024. Mathematical modeling of SARS-CoV-2 variant substitutions in European countries: transmission dynamics and epidemiological insights

Víctor López de Rioja[SUP] 1 [/SUP], Aida Perramon-Malavez[SUP] 1 [/SUP], Sergio Alonso[SUP] 1 [/SUP], Cristina Andrés[SUP] 2 3 [/SUP], Andrés Antón[SUP] 2 3 [/SUP], Antoni E Bordoy[SUP] 4 [/SUP], Jordi Càmara[SUP] 5 6 [/SUP], Pere-Joan Cardona[SUP] 4 6 [/SUP], Martí Català[SUP] 7 [/SUP], Daniel López[SUP] 1 [/SUP], Sara Martí[SUP] 5 6 [/SUP], Elisa Martró[SUP] 4 8 [/SUP], Verónica Saludes[SUP] 4 8 [/SUP], Clara Prats[SUP] 1 [/SUP], Enrique Alvarez-Lacalle[SUP] 1 [/SUP]



Affiliations
Abstract

Background: Countries across Europe have faced similar evolutions of SARS-CoV-2 variants of concern, including the Alpha, Delta, and Omicron variants.
Materials and methods: We used data from GISAID and applied a robust, automated mathematical substitution model to study the dynamics of COVID-19 variants in Europe over a period of more than 2 years, from late 2020 to early 2023. This model identifies variant substitution patterns and distinguishes between residual and dominant behavior. We used weekly sequencing data from 19 European countries to estimate the increase in transmissibility (Δβ)




between consecutive SARS-CoV-2 variants. In addition, we focused on large countries with separate regional outbreaks and complex scenarios of multiple competing variants.

Results: Our model accurately reproduced the observed substitution patterns between the Alpha, Delta, and Omicron major variants. We estimated the daily variant prevalence and calculated Δβ

between variants, revealing that: ( i ) Δβ increased progressively from the Alpha to the Omicron variant; ( ii ) Δβ showed a high degree of variability within Omicron variants; ( iii ) a higher Δβ was associated with a later emergence of the variant within a country; ( iv ) a higher degree of immunization of the population against previous variants was associated with a higher Δβ for the Delta variant; ( v ) larger countries exhibited smaller Δβ, suggesting regionally diverse outbreaks within the same country; and finally ( vi
) the model reliably captures the dynamics of competing variants, even in complex scenarios.

Conclusion: The use of mathematical models allows for precise and reliable estimation of daily cases of each variant. By quantifying Δβ,
we have tracked the spread of the different variants across Europe, highlighting a robust increase in transmissibility trend from Alpha to Omicron. Additionally, we have shown that the geographical characteristics of a country, as well as the timing of new variant entrances, can explain some of the observed differences in variant substitution dynamics across countries.



Keywords: SARS-COV-2 variants; effective reproduction number; epidemiological modeling; epidemiological timing; genomic surveillance; transmissibility; vaccination rates; variant substitution.

 
Back
Top Bottom